Literature DB >> 20511341

Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice.

Chi Duong1, Huei Jiunn Seow, Steven Bozinovski, Peter J Crack, Gary P Anderson, Ross Vlahos.   

Abstract

Reactive oxygen species (ROS) produced from cigarette smoke cause oxidative lung damage including protein denaturation, lipid peroxidation, and DNA damage. Glutathione peroxidase-1 (gpx-1) is a detoxifying enzyme that may protect lungs from such damage. The aim of this study was to determine whether gpx-1 protects the lung against oxidative stress-induced lung inflammation in vivo. Male wild-type (WT) or gpx-1(-/-) mice were exposed to cigarette smoke generated from nine cigarettes per day for 4 days to induce oxidative stress and lung inflammation. The effect of the gpx mimetic ebselen on cigarette smoke-induced lung inflammation was evaluated when given prophylactically and therapeutically, i.e., during established inflammation. Mice were killed, and the lungs were lavaged with PBS and then harvested for genomic and proteomic analysis. Gpx-1(-/-) mice exposed to cigarette smoke had enhanced BALF neutrophils, macrophages, proteolytic burden, whole lung IL-17A, and MIP1alpha mRNA compared with WT mice. The gpx mimetic ebselen (10 and 100 microM) inhibited cigarette smoke extract-induced oxidation of MH-S cells in vitro and inhibited cigarette smoke-induced increases in BALF macrophages, neutrophils, proteolytic burden, and macrophage and neutrophil chemotactic factor gene expression when administered prophylactically. In addition, ebselen inhibited established BALF inflammation when administered therapeutically. These data show that gpx-1 protects against cigarette smoke-induced lung inflammation, and agents that mimic the actions of gpx-1 may have therapeutic utility in inflammatory lung diseases where cigarette smoke plays a role.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511341     DOI: 10.1152/ajplung.00038.2010

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  30 in total

Review 1.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

Review 2.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

Review 3.  NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?

Authors:  Joanna Wieczfinska; Milena Sokolowska; Rafal Pawliczak
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 4.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

Review 5.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

6.  Targeting c-Src Reverses Accelerated GPX-1 mRNA Decay in Chronic Obstructive Pulmonary Disease Airway Epithelial Cells.

Authors:  Abdoulaye J Dabo; Wendy Ezegbunam; Anne E Wyman; Jane Moon; Christopher Railwah; Alnardo Lora; Susan M Majka; Patrick Geraghty; Robert F Foronjy
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

Review 7.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

8.  The glutathione peroxidase 1-protein tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant of airway inflammation and alveolar destruction.

Authors:  Patrick Geraghty; Andrew A Hardigan; Alison M Wallace; Oleg Mirochnitchenko; Jincy Thankachen; Leo Arellanos; Victor Thompson; Jeanine M D'Armiento; Robert F Foronjy
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

Review 9.  Glutathione peroxidase-1 as a novel therapeutic target for COPD.

Authors:  Ross Vlahos; Steven Bozinovski
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

10.  Nox1 causes ileocolitis in mice deficient in glutathione peroxidase-1 and -2.

Authors:  Robert S Esworthy; Byung-Wook Kim; Joni Chow; Binghui Shen; James H Doroshow; Fong-Fong Chu
Journal:  Free Radic Biol Med       Date:  2013-12-25       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.